NCT07274683
Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness
StatusNot Yet Recruiting
PhaseNot applicable
SponsorBeijing Tiantan Hospital
Primary completion (estimated)
At risk: Primary completion moved at least 12 months later, primary endpoint(s) modified.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jul 1, 2026 to Jul 2027 Show 6 more changesShow less
- Primary endpoint(s) modified
- Phase changed: Not specified → Not applicable
- Start date: Jan 1, 2026 to Oct 2026
- Eligibility criteria expanded, about 20 words
- Study completion pushed from Jan 1, 2027 to Dec 2027
- Secondary endpoints: 5 to 13
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
The change in total sleep time
Timeframe: from the baseline night (the night before surgery) to the night of surgery (postoperative night 1)
Secondary (13)
sleep structure before and after SGB
sleep latencies before and after SGB
sleep stage distribution before and after SGB
Change in cerebral oxygen saturation
Change in cerebral hemodynamic parameters
Show 8 moreShow less
the recovery of consciousness
Length of ICU stay
Costs of ICU stay
Safety outcomes
Feasibility outcomes
SGB success rate
PSG data completeness
adverse event rate
Arms and interventions
stellate ganglion blockExperimental
preoperative administration of stellate ganglion block
Drugs: stellate ganglion block with 0.5% ropivacaine
Sites
1 site in 1 country
- Beijing Tian Tan HospitalBeijing, China